已收盘 11-28 16:00:00 美东时间
-0.160
-3.14%
今日重点评级关注:HC Wainwright & Co.:维持Oncolytics Biotech"买入"评级,目标价从5美元升至10美元;HC Wainwright & Co.:维持Barinthus Biotherapeutics"买入"评级,目标价从3美元升至4美元
11-18 15:28
HC Wainwright & Co. analyst Heiko F. Ihle maintains Atlas Lithium (NASDAQ:ATLX) with a Buy and lowers the price target from $18 to $12.
11-17 19:44
Atlas Lithium (NASDAQ:ATLX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.64) by 45.31 percent. This is a 41.67 percent increase over losses of $(0.60) per share from the
11-14 06:17
Shares of lithium-related stocks are trading lower. The White House announced i...
11-04 03:51
Shares of lithium-related stocks are trading lower. The continued threat of a p...
10-27 23:58
Gainers Electra Battery Materials (NASDAQ:ELBM) stock increased by 10.4% to $2...
10-16 05:06
Shares of lithium companies are trading higher amid possible sympathy with an o...
10-09 00:15
Shares of lithium-related companies are trading higher amid sympathy with Lithi...
09-24 04:34
Strategic Partnership Model Allows for Near-Term Cash Flow GenerationBoca Raton, Florida--(Newsfile Corp. - September 2, 2025) - Atlas Lithium Corporation (NASDAQ:ATLX) ("Atlas Lithium" or "Company"), a leading lithium
09-02 20:12